Inflammatory bowel disease (IBD) is a systemic inflammatory affecting multiple organs apart from intestinal tract, ocular complications account for approximately 5%. These range from uveitis, episcleritis, scleritis and keratopathy. Treatment involves systemic and local ocular therapy in the form of 5-aminosalicylate agents, steroids, immunosuppressants or biological agents in severe disease. We report a case of 21 year old young female presented with bloody diarrhea and acute onset visual loss diagnosed to have severe ulcerative colitis complicated with acute anterior uveitis.
Case Report
A 21 year unmarried female with no prior comorbidities presented to emergency room with the complaints of loose stools for a duration of 2 weeks along with intermittent fever. Patient gave a history of initially passing 15 to 20 episodes of loose stools/day which were green colored and non-blood stained. The frequency was later decreased to 10 episodes/day upon receiving oral antibiotics on outpatient basis. Loose stools were associated with intermittent cramping abdominal pain. Patient also had complaints of bilateral knee and ankle joint swellings associated with pain since past 1week. No similar complaints were present in the family. 
Inflammatory poly-arthritis
After 5 days of inpatient treatment with above mentioned therapy, patient had full recovery of vision,frequency of stools decreased to <3 / day and were non-blood stained. Patient was discharged with T Mesalamine 800mg 2-2-1, Prednisolone 40mg OD and Oral Calcium 500mg OD. Patient was advised for follow up with Gen Med, MGE and Ophthal departments. 
Discussion
Extraintestinal Manifestations In IBD are most likely mediated by the inflammatory nature of the disease. Circulating antigen-antibody complexes or autoantibody production against cellular antigens shared by the colon and extra-intestinal organs. Inflammation causing damage to the mucosal intestinal epithelium may allow proteins or microorganisms to pass through the intestinal barrier and cause a reactive lymphoid tissue response. This in turn results in antibody production or antigen-antibody complexes that circulate in the body and cause systemic inflammation. Ocular manifestations are reported more frequently in patients with CD (3.5%-6.3%) than patients with UC (1.6%-4.6%) and include episcleritis and uveitis. Patients older than 40 years have more likely iritis /uveitis than those younger than 40 years. Patients with colitis and ileo-colitis tend to have a higher risk of ocular involvement compared to those with ileitis alone. 
